Co-founder and CEO
Kintsugi Therapeutics
Kintsugi Therapeutics develops targeted biopharmaceutical therapies that leverage proprietary biomarker-driven methodologies to enhance treatment efficacy for patients with chronic diseases. The company focuses on improving patient outcomes by minimizing side effects associated with complex medical conditions.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$1.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Kintsugi Therapeutics develops targeted biopharmaceutical therapies that leverage proprietary biomarker-driven methodologies to enhance treatment efficacy for patients with chronic diseases. The company focuses on improving patient outcomes by minimizing side effects associated with complex medical conditions.